共 50 条
Sequence analysis of P21-activated kinase 3 (PAK3) in chronic schizophrenia with cognitive impairment
被引:10
|作者:
Morrow, Eric M.
[1
,2
,3
,4
]
Kane, Anna
[1
,2
,3
]
Goff, Donald C.
[4
]
Walsh, Christopher A.
[1
,2
,3
]
机构:
[1] Harvard Univ, Childrens Hosp Boston, Sch Med, Div Genet, Boston, MA 02115 USA
[2] Howard Hughes Med Inst, Div Neurogenet, Chevy Chase, MD USA
[3] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA USA
[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat,Schizophrenia Res Program, Boston, MA 02114 USA
关键词:
Schizophrenia;
Mental retardation;
Pfropfschizophrenie;
P21-activated kinase PAK3;
Cognitive development;
D O I:
10.1016/j.schres.2008.08.021
中图分类号:
R749 [精神病学];
学科分类号:
100205 ;
摘要:
The P27-activated kinase PAK3 is critical for cognitive development and truncating mutations cause non-syndromic mental retardation (MR). Missense mutations are also associated with psychotic disorders, most commonly with schizophrenia involving premorbid MR, namely "pfropfschizophrenie". We set out to measure the frequency of sequence variants in PAK3 in schizophrenia without premorbid MR. We conducted complete gene reseqeuncing of all coding exons and exon-intron boundaries in patients with schizophrenia with cognitive impairment but without premorbid MR. Deleterious variants in schizophrenia alone were rare (<1/ 159 or 0.6%). Thereby, while PAK3 remains a strong biological candidate in psychosis, evidence from human genetics provides strongest support for a link to pfropfschizophrenie and not to schizophrenia without premorbid intellectual disability. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:265 / 267
页数:3
相关论文